David M. Cross
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
-
- Cancer-related Molecular Pathways
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 4
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Martin K. Bayliss (1 shared paper)Ruth E. Feltell (2 shared papers)Neil T. Thompson (2 shared papers)Nicola G. Wallis (2 shared papers)John F. Lyons (2 shared papers)Donna-Michelle Smith (1 shared paper)Edward J. Lewis (1 shared paper)Matthew Squires (1 shared paper)
- Journals
- Regulatory Toxicology and Pharmacology (3 papers)British Journal of Clinical Pharmacology (2 papers)Xenobiotica (2 papers)Biochemical Society Transactions (1 paper)Alzheimer s & Dementia Translational Research & Clinical Interventions (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
David M. Cross
18 papers receiving 379 citations
Peers
Comparison fields: 5 of 69
- Pharmacology 44
- Oncology 112
- Molecular Biology 171
- Pulmonary and Respiratory Medicine 70
- Cell Biology 38
Countries citing papers authored by David M. Cross
This map shows the geographic impact of David M. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Cross more than expected).
Fields of papers citing papers by David M. Cross
This network shows the impact of papers produced by David M. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Cross. The network helps show where David M. Cross may publish in the future.
Co-authors
The 25 scholars most cited alongside David M. Cross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 136 | |
| 2 | 2011 | 65 | |
| 3 | 2000 | 56 | |
| 4 | 1986 | 21 | |
| 5 | 2012 | 21 | |
| 6 | 2021 | 14 | |
| 7 | 2020 | 14 | |
| 8 | 2012 | 11 | |
| 9 | 2012 | 10 | |
| 10 | 1988 | 9 | |
| 11 | 2011 | 6 | |
| 12 | 1995 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2012 | 4 | |
| 17 | 2012 | 3 | |
| 18 | 1990 | 1 |
About David M. Cross
David M. Cross is a scholar working on Molecular Biology, Oncology, Small Animals, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 391 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), Pulmonary Hypertension Research and Treatments (3 papers), Renin-Angiotensin System Studies (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Antifungal resistance and susceptibility (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Animal testing and alternatives (2 papers). The work is most often cited by research in Pharmacology (44 citations), Oncology (112 citations), Molecular Biology (171 citations), Pulmonary and Respiratory Medicine (70 citations) and Cell Biology (38 citations). David M. Cross has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Martin K. Bayliss, Ruth E. Feltell, Neil T. Thompson, Nicola G. Wallis, John F. Lyons, Donna-Michelle Smith, Edward J. Lewis, Matthew Squires, R.B. Kemp and Elizabeth Horsley. Their work appears in journals such as Regulatory Toxicology and Pharmacology, British Journal of Clinical Pharmacology, Xenobiotica, Biochemical Society Transactions and Alzheimer s & Dementia Translational Research & Clinical Interventions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.